Propylene Glycol Alginate, CAS# 9005-37-2, is a organic chemicals manufactured through chemical synthesis, available as White to off-white powder . Propylene Glycol Alginate is widely used as thickeners. It is widely accepted as safe food additive in many countries with E number E405.
Using of Propylene Glycol Alginate in large quantity could lead to irritation, nausea, coughing and wheezing.
Ingestion of Propylene Glycol Alginate in large quantity may hurt our health, please follow the guideline of using Propylene Glycol Alginate: ADI 0-25 mg/kg body weight
Special groups refer to newborns, children, pregnant and any other applicable vulnerable groups.
Propylene Glycol Alginate may have some affect on infants, children under 4 and pregnant women. We recommend consumers to consult professionals before using Propylene Glycol Alginate in food of infants, children under 4 and pregnant women.
Generally recognized as safe(GRAS) is a FDA designation that a specific substance or ingredient is generally considered safe by experts, and so is exempted from the usual Federal Food, Drug, and Cosmetic Act (FFDCA) food additive tolerance requirements. Propylene Glycol Alginate is considered safe by FDA according to existing data and granted GRAS status.
No breaking news or public health crises reported about Propylene Glycol Alginate reported up to now.
* Want to report news about this ingredient, please send email to foodchemmis08@foodchem.cn. Your knowledge can help us to uncover more truthes about food ingredients to customers.
1. Effects of propylene glycol alginate and sucrose esters on the physicochemical properties of modified starch-stabilized beverage emulsions. [Molecules. 2014 Jun 24]
Author: Cheong KW, Mirhosseini H, Hamid NS, Osman A, Basri M, Tan CP.
2. Determination of M/G ratio of propylene glycol alginate sodium sulfate by HPLC with pre-column derivatization. [Carbohydr Polym. 2014 Apr 15]
Author: Wu J, Zhao X, Ren L, Xue Y, Li C, Yu G, Guan H.
3. Enamel matrix derivative in propylene glycol alginate for treatment of infrabony defects with or without systemic doxycycline: 12- and 24-month results. [J Periodontol. 2014 May]
Author: Eickholz P, Röllke L, Schacher B, Wohlfeil M, Dannewitz B, Kaltschmitt J, Krieger JK, Krigar DM, Reitmeir P, Kim TS.
4. Interfacial and foaming interactions between casein glycomacropeptide (CMP) and propylene glycol alginate. [Colloids Surf B Biointerfaces. 2012 Jun 15]
Author: Martinez MJ, Pizones Ruiz-Henestrosa VM, Carrera Sánchez C, Rodríguez Patino JM, Pilosof AM.
5. Integrative design of a poly(ethylene glycol)-poly(propylene glycol)-alginate hydrogel to control three dimensional biomineralization. [Biomaterials. 2011 Apr]
Author: Cha C, Kim ES, Kim IW, Kong H.